Heron Therapeutics, Inc.HRTXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank36
3Y CAGR-20.1%
5Y CAGR-16.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-20.1%/yr
vs -0.7%/yr prior
5Y CAGR
-16.2%/yr
Recent deceleration
Acceleration
-19.4pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
6 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $116.09M | -0.9% |
| 2024 | $117.17M | -32.1% |
| 2023 | $172.55M | -24.1% |
| 2022 | $227.46M | -11.9% |
| 2021 | $258.15M | -8.0% |
| 2020 | $280.61M | -4.9% |
| 2019 | $295.04M | +26.1% |
| 2018 | $233.90M | +6.0% |
| 2017 | $220.74M | +28.2% |
| 2016 | $172.16M | - |